Program to reduce food insecurity for hospitalized diabetics

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This program aims to tackle food insecurity among hospitalized patients with Type 1 and Type 2 diabetes by implementing a comprehensive nutrition intervention. Participants will be randomly assigned to receive enhanced access to nutritious meals and educational resources, or to standard care. The study will evaluate the impact of this intervention on health outcomes and community engagement. By addressing food disparities, the program seeks to improve the overall well-being of diabetic patients during and after their hospital stay.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of Type 1 or Type 2 Diabetes Mellitus
* Admitted to Stanford Healthcare inpatient unit
* Residence in California at time of enrollment
* Positive Screening for Food Insecurity
* On a Healthcare Plan covered by Mom's Meals.

Exclusion Criteria:

* Plans to be discharged to a skilled nursing facility.
* Patients who prefer a language for which a short-form consent is not available.
* No Home Address
* Pregnant Participants.
* No access to refrigerator.

Where it's running

• Stanford Medicine
  Palo Alto, California, United States Recruiting

Study contacts

• Principal investigator: Neera Ahuja, MD — Stanford University
• Study coordinator: Christine Santiago, MD
• Email: csantia2@stanford.edu
• Phone: (650) 725-5071

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes

  This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.

  Recruiting Fidam Rdc · Bad Mergentheim, Baden-Wurttemberg · NCT07814508

• Diabetes multimorbidity and a voice diary app to help self-manage

  This study tests whether the Fabla-diabetesMM audio diary app is feasible and helpful for older adults with type 1 or type 2 diabetes who also have additional chronic conditions.

  Recruiting Emory University · Atlanta, Georgia · NCT07474376

• Eversense Gemini system with new flash glucose feature — testing accuracy and safety

  This will test whether the Eversense Gemini wearable glucose monitor with a new flash feature gives accurate and safe glucose readings for adults with type 1 or type 2 diabetes.

  Recruiting Senseonics, Inc. · Escondido, California · NCT07386340

• Evaluating LY4057996 in Healthy Individuals and Those with Type 1 and Type 2 Diabetes

  This study is testing a new drug called LY4057996 to see how well it is tolerated and what side effects it might have in healthy people and those with Type 1 or Type 2 diabetes.

  Recruiting Phase 1 Eli Lilly and Company · Neuss · NCT06945406

• Comparing single-session and multiple-session laser treatment for diabetic eye disease

  This study is testing whether one session or multiple sessions of laser treatment works better for people with newly diagnosed diabetic eye disease to help them keep their vision and avoid complications.

  Recruiting Vastra Gotaland Region · Mölndal · NCT06549023

• Biobank for studying ALS and Alzheimer's diseases

  This study is collecting blood, skin samples, and health information from people to see how genetics might help us understand and find treatments for ALS and Alzheimer's disease.

  Recruiting New York Stem Cell Foundation Research Institute · New York, New York · NCT06203106

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.